PACAP-38 (Human)
PACAP38 | Pituitary Adenylate Cyclase Activating Polypeptide 38 (Human)
(Ovine, Rat)

4221-v 0.5 mg | 255.00 EUR

His – Ser – Asp – Gly – Ile – Phe – Thr – Asp – Ser – Tyr – Ser – Arg – Tyr – Arg – Lys- Gln – Met – Ala – Val – Lys – Lys – Tyr – Leu – Ala – Ala – Val – Leu- Gly – Lys – Arg – Tyr – Lys – Gln – Arg – Val – Lys – Asn – Lys – NH₂

Synthetic Product

The purity of PACAP-38 (Human) is guaranteed to be higher than 99% by HPLC

The biological activity of our peptide PACAP-38 is examined by the Division of Pharmacology, Peptide Institute, Inc.

The neuropeptide PACAP-38 | Pituitary Adenylate Cyclase Activating Polypeptide 38, was originally isolated from hypothalamus. PACAP-38 shows higher activity than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase. This multifuncional neuropeptide acts also as inhibitor for gastrin secretion.
PACAP-38 and its N-terminal analog PACAP-27 interacts with the type I receptor in same manner, whereas both peptides have much lower affinity to the type II receptor.

Shipping | Storage | Stability
Our product PACAP-38 | Pituitary Adenylate Cyclase Activating Polypeptide 38 will be shipped at room temperature. Information about product specific storage conditions will be found on the vial. Stock solutions should be stored at -20°C. Please avoid repeated freezing and thawing by preparing aliquots.

References:

1. A. Miyata, A. Arimura, R.R. Dahl, N. Minamino, A. Uehara, L. Jiang, M.D. Culler and D.H. Coy, Biochem. Biophys. Res. Commun., 164, 567 (1989) (Original)

The synthetic 38 mer polypeptide PACAP38 | Pituitary Adenylate Cyclase Activating Polypeptide 38 (Human) is distributed through Peptide Institute, Inc. under the license of Tulane University.